U.S. Markets open in 6 hrs 46 mins

Inogen, Inc. (INGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
68.42+1.41 (+2.10%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close67.01
Open66.99
Bid0.00 x 1000
Ask0.00 x 800
Day's Range64.18 - 68.48
52 Week Range26.57 - 69.00
Volume48,693
Avg. Volume144,766
Market Cap1.528B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Business Wire

    Inogen Announces Appointment of General Counsel

    GOLETA, Calif., Jun 21, 2021--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Jason Somer as Inogen’s Executive Vice President and General Counsel and Secretary, effective July 12, 2021.

  • Business Wire

    Inogen Announces Appointment of Chief Medical Officer

    Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that its Board of Directors has appointed Dr. Stanislav Glezer as Inogen’s Executive Vice President and Chief Medical Officer, effective June 21, 2021.

  • Business Wire

    Inogen Strengthens Board of Directors with Addition of Elizabeth Mora

    Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, announced today that Elizabeth (Beth) Mora has been appointed to its Board of Directors, effective May 24, 2021. In addition, Ms. Mora was appointed as a member of the Board’s Audit Committee. She will serve as a Class I director, with a term expiring at the annual meeting of stockholders to be held in 2024. Ms. Mora fills the vacancy on the Board and the Board’s Audit Committee created by the resignation of R. Scott Greer, who resigned effective May 24, 2021. Mr. Greer had served as a member of Inogen’s Board since 2015. In connection with this transition, Mr. Loren McFarland, an existing member of the Audit Committee, was appointed as Chairperson of the Board’s Audit Committee and Ms. Mora was appointed as a member of the Board’s Audit Committee, in each case effective May 24, 2021.